Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Diabetes
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
No Bolusing with Closed Loop
3
Mins
August 2024
This article reviews real-world data presented at the ADA Scientific Sessions 2024. It demonstrates the glycaemic range when Control-IQ Technology users do not manually bolus for extended periods
Read more
9
Mins
5th November 2019
Rewriting Medical Textbooks: The Kidney as a Window to the Heart – The Role of Sodium–Glucose Transport Protein 2 Inhibitors in Cardiovascular and Renal Disease in Type 2 Diabetes Mellitus
The objectives of the meeting were to actively exchange scientific knowledge with the faculty and the audience on Type 2 diabetes mellitus….
11th January 2018
Real-World Challenges in Type 2 Diabetes Mellitus: Why a Paradigm Shift Is Needed
The objective of this symposium was to provide an overview of the challenges in T2DM treatment and to discuss novel strategies that may overcome real-…
8
Mins
31st October 2017
Session One: Basal Insulins: Still Innovating After All These Years
Advances in understanding diabetes pathophysiology and treatment permit individualised therapy based on patient-centred treatment plans.
12
Mins
31st October 2017
Session Two: Changing the Type 2 Diabetes Mellitus Management Paradigm with Fixed-Ratio Combinations
Fixed-ratio combinations, the co-administration of two injectable therapies in a formulation that can be adjusted through titration, are changing the…
19
Mins
31st October 2017
Session Three: Innovating Beyond Glucose Control in Diabetes Care
Advances in treatment offerings are moving beyond classical considerations around glucose control to focus on other aspects of the disease.
13
Mins
27th October 2016
Type 2 Diabetes Mellitus: Beyond the Beta Cell
Type 2 diabetes mellitus (T2DM) currently affects >8% of the world population. It is the leading cause of blindness, end-stage kidney disease, and…
3rd November 2015
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?
This symposium aimed to address the current issues in the management of patients with Type 2 diabetes (T2D) post-acute coronary syndrome (ACS), bringing…
31st October 2014
Investigating the Different Dimensions of DPP-4 Inhibitors
This Takeda-sponsored European Association for the Study of Diabetes (EASD) symposium addressed the pharmacology, clinical use, and future therapeutic…
Loading posts...
« Previous
1
2
3
Next »